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Introduction
Asthma affects over 300 million persons worldwide and [1] and is the most common chronic disease in childhood. The increasing prevalence of asthma over the last few decades represents a major public health concern [2] [3, 4] . Both genetic and environmental factors contribute asthma development. For many with allergic asthma, the disease begins in early childhood and researchers have suggested the lack of exposure to bacteria and parasites has led to a dysregulated immune response in individuals affected by allergies and asthma [5] [6] [7] [8] . This theory, called the 'hygiene hypothesis', is supported by observations that people in resource-rich regions have more allergies and auto-immune disease than individuals in resource-poor regions [9] .
According to the hygiene hypothesis microbial exposures of the respiratory and gastrointestinal tracts early in life prompt immune maturation and may inhibit the development of allergic diseases and asthma [10] [6] [11] . Subsequently, children raised in modern metropolitan life styles, relatively reduced in the natural microbial burden, may have unbalanced immune systems in infancy, thereby allowing for an 'allergic march' -a pattern of pro-allergic immune development and disorders that occurs in early life. Studies have shown the use of antibiotics during infancy correlated with an increased risk of developing asthma, suggesting that bacterial infections early in life may help to inhibit asthma development [12] . As illustrated in recent reports, inverse relationships were observed between the presence of endogenous bacteria, Helicobacter pylori, and both asthma and atopic conditions in children [13, 14] .
Mycobacteria tuberculosis (M. tb) infects one third of the world's population. New models are in broad agreement that human TB originated at least 35,000 years ago [15] and phylogenetic evidence from molecular studies of the entire M. tb complex indicates an African origin perhaps more than 2.5 million years ago [16] . Among individuals infected with M.tb, only about 5-10% progress to active disease and the rest of infected individuals remain asymptomatic. Progression generally occurs in individuals with less effective immune systems such as the very young, old or those who suffer from malnourishment or other diseases such as HIV infection. The high prevalence of asymptomatic infection indicates a possible commensalism between human host and bacterial pathogen [17] .
As M. tb is transmitted through respiratory aerosols and disease manifestations usually involve the pulmonary system, it is intriguing to apply the 'hygiene hypothesis' to the local respiratory system.
It is possible infection with M. tb in developing immune systems, such as in children, may 'immunize' against an allergic march towards asthma. We postulated an inverse relationship between M. tb infection and either asthma or atopic conditions in children. Using data from the National Health and Nutrition Examination Survey (NHANES) 1999-2000, we tested the hypothesis.
Patients and Methods
The NHANES is a series of cross-sectional, nationally representative, health examination survey performed in the United States of America. The National Center for Health Statistics, Centers for Disease Control and Prevention periodically conducts the survey. Beginning in 1999, the NHANES became a continuous annual survey of 5000 people rather than a periodic survey [18] . The survey protocol was approved by the institutional review board of the Centers for Disease Control and Prevention. All the participants gave written informed consent.
The NHANES 1999-2000 uses a stratified, multistage, probability sample of the civilian noninstitutionalized USA population. NHANES 1999-2000 oversampled low-income persons, adolescents, persons aged 60 years and older, African Americans, and Mexican Americans to support separate analyses [18] . Among the 12,160 persons selected, a total of 9,965 (81.9%) underwent 
Definition of Asthma:
A 'history of asthma' was based on participant response to the question: "Has a doctor or other health professional ever told you that you have asthma?" Those who responded in the affirmative were considered as having asthma. Those who did not answer this question were excluded from the analysis. Subjects with a history of asthma were grouped into two categories; those with a recent asthma attack in the previous 12 months and those reporting a last asthma attack over a year ago.
Secondary outcome variables included dermatologic and other respiratory symptoms such as symptoms of wheezing, dermatitis, and hay fever.
Statistical analysis
To account for the complex survey design and to incorporate sample weights, all analyses were performed with SAS Version 9.2 survey procedure (SAS Institute). Additionally, we used the recommended 2-year sample weight (variable name: wtsmec2y) to adjust for non-response bias and the oversampling of NHANES. Distribution of potential confounders was compared between those with and without physician-diagnosed asthma using chi-square statistics. We estimated odds ratios (ORs) associations with logistic regression. The ORs were adjusted for age, gender, race, country of birth and smoking status when comparing the M. tb infected and BCG association to asthma, allergies and atopic dermatitis. Multiplicative Interaction between age and PPD result with respect to the risk of asthma, wheezing, or atopic allergy in the past year, was tested using the cross-product term in logistic regression model. A P-value of 0.05 was considered significant.
Results

M. tb infection in the Study Population:
A total of 9,965 individuals, ages 1 year or older, participated in NHANES 1999-2000. The median age in the study population was 25 years. Among these participants 7,613 (74.1% of total) reported no serious prior positive reaction to a TST and had undergone a tuberculin skin test with PPD. Only 7,386 (83.63%) had valid test results and were included in this analysis.
In total, 407 (4.1%) participants had a positive skin test. Skin test positivity varied in relation to demographic factors, consistent with a well-recognized trend observed in a prior study [19] . The participants more likely to be infected with M. tb were older men, cigarette smokers and born outside the United States of America. For children age <20 years, 71(1%) had a positive skin test reaction (Table 1) . Skin test positivity in children and adolescents was associated with older age, being Mexican-American, born outside the USA and prior BCG vaccination.
Asthma Status in the Study Population:
A total of 946 (13.6%) individuals reported a history of asthma. Asthma prevalence was associated with the following factors: younger age, being non-Hispanic black, and birth in the USA.
Among children < 20 years, 535 (17.3%) had a history of asthma. On average, the children and adolescents more likely to have asthma were older, male, and born in the USA.
Association between M. tb infection and Asthma:
In all participants, a trend suggesting an inverse relationship between M. tb infection and that of ever having asthma or having asthma attack in the past year exists but was not statistically significant (data not shown). However, this association was stronger and significant in participants < BCG association between asthma, atopic dermatitis and allergic rhinitis:
In all subjects, having a history of BCG vaccination was not related to having a history of asthma. This observation was consistent between age groups while adjusting for other factors, with an OR of 1.4 (95%CI 0.98-2.05) and 1.5 (95%Ci 0.97-2.07) in adults and participants < 20 years respectively. Similarly, there was no association between BCG status and atopic dermatitis for adults and participants < 20 years; 1.2 (95%CI 0.82-1.53) and 1.3 respectively (95%C.I. 0.83-1.55).
Discussion:
To our knowledge, this study is the first to report an inverse association between asthma and M. tb infection in a region of low TB incidence and high prevalence of childhood asthma. In this large study of a nationally representative population, children infected with M. tb were significantly less likely to have a history of asthma or symptoms of asthma over the prior year than children not infected with M. tb. This finding was not secondary to BCG vaccination, a common cause of TST cross reactivity, as no associations between BCG status and asthma were observed.
Interestingly, the inverse associations between M. tb infection and asthma were significantly pronounced only in children and adolescents and not in adults surveyed in the NHANES. Similar agedependent findings were observed by the International Study of Asthma and Allergies in Childhood, an ecological study in over 700,000 children ages 6-7 years and 13-14 years from 56 countries [20, 21] . The younger group of children, ages 6-7 years, were significantly (p<0.0001) less likely to have wheezing in the prior 12 months in regions where TB notification rates and WHO TB incidence rates were high whereas this inverse association was not significant (p=0.263) in the older group of children, ages 13-14 years, surveyed [20] . It is possible that any protective effect M. tb infection may induce in the respiratory system against asthma may be most effective at a critical time, as the immune system is developing and being stimulated from self and non-self, i.e. microbe and allergen antigens.
Prior studies performed in TB-endemic regions investigated associations between BCG vaccination and asthma. Reports varied between no associations [22] [23] [24] [25] or weak inverse associations [26] . A systemic review and meta-analysis of epidemiological studies found that BCG vaccination indicated a modest protective effect against the development of childhood asthma with an overall pooled OR of 0.86 (95% CI 0.79-0.93) [27] . Several studies report inverse relationships between TST reactions and atopic disorders [28, 29] and one recent study found no association between an interferon-gamma release assay and atopy [30] . A cross-sectional analysis on 23 studies examining mycobacterial infection and atopy report a significant inverse correlation (OR 0.63; 95% CI: 0.51-0.79) [31] . We found no association between BCG vaccination and asthma or atopic symptoms in all participants, including children and adolescents.
Environmental and microbial exposure in various mucosal sites is important for the development of the immune system in children [32] . In this respect, a fine balance between T cell subsets, including Th1, Th2, Th17 and Regulatory T cells (Tregs) is central in determining a child's predilection towards asthma. Supporters of the hygiene hypothesis suggest modern lifestyles cause an imbalance shift towards Th2 immune responses [33, 34] which drive asthma development in susceptible individuals. Infection with M. tb not only increases the effector T cell responses [35] [36] [37] but has recently been shown to increase the frequency of Tregs in the airways [38, 39] . Tregs are known to play a role in controlling Th2-mediated inflammation in asthmatic patients [40] and it was recently observed the frequency and function of Tregs were reduced in bronchoalveolar lavage samples from asthmatic children [41] .
An eventual hope for the treatment of allergic airway disease is to design therapies or vaccines that stimulate endogenous Tregs [42] . That M. tb could be protective against asthma is biologically plausible, either through recruitment or stimulation of pulmonary Tregs. Recent work performed in the murine model yielded convincing data supporting the concept that mycobacterial infection conferred protection, either prophylacticly or therapeutically against allergen-induced asthma. Several studies have shown that prophylaxis treatment with both live and heat killed BCG leads to a polarized Th1 immune response in the lung and inhibits the development of allergeninduced Th2 responses [5, [43] [44] [45] [46] . The application of live or dead mycobacteria inhibit the recruitment and expansion of Th2 cells homing into the lung, increase IFN-γ levels and decrease the eosinophilia after ovalbumin airway challenge. A recent pilot study investigated the effect of intranasal delipidated acid-treated M. vaccae on adults with asthma and found no significant difference between the treatment group and placebo [47] . The results from the M. vaccae study may not be surprising, for timing of microbe or allergen co-exposure appears to be relevant. As illustrated in the murine model of allergic airway disease, transfer of allergen specific Tregs prevented, though did not reverse, airway remodeling changes in a chronic challenge model [48, 49] , possibly illustrating that a developing immune system may hold greater potential for abating asthmatic inflammation.
Potential limitations of the present study include the use of a cross-sectional study design and self-reported health data. The TST remains an imperfect diagnostic tool for M. tb infection, as false positive reactions can be associated with non-tuberculosis mycobacteria and BCG vaccination.
Additionally, the use of self-reported data on asthma and atopic conditions may have led to recall bias, though prior studies have suggested that self-reported information on asthma has acceptable validity and reliability [50, 51] . Indeed M. tb is an ancient member of the human microbiota and its absence may not be correlated with the recent and on-going epidemic of asthma and related allergic disorders. It is possible that changes in human micro-ecology such as increasing trends of obesity, tobacco exposures, air pollution and indoor environmental triggers account for the increase in asthma over the past few decades; and there is no causative relationship between M. tb infection and childhood asthma.
Conclusion:
The mycobacterial disease tuberculosis has plagued Homo sapiens, and probably our hominid ancestors, for millennia. Despite our long co-evolutionary history, M. tb has not reduced in virulence to a state of benign commensalism with humans. However, there appears to be enough evidence from this and prior studies to warrant future asthma research to explore possible preventative effects from inhaled inactivated mycobacterium. 
